However, despite the fact that GR expression in mammary tissue declines from normal to precancerous lesions and to invasive breast carcinoma (54, 78), the increment in stress hormones during breast cancer progression results in GR activation even at distant metastatic sites. Here, NR3C1 is linked to breast cancer.